Adverse Adolescent Pathways to Substance Use
NCT06977178
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Purpose: This 5-year R01 study will elucidate the role of maturational change across adolescence in neural connectivity and physiological stress responses in the relationship between anxiety and adverse pathways to substance use (APSU). Participants: Children (N=200) aged 12-14 with symptoms of anxiety and their legal caregiver will be recruited from clinical and community sources.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Anxiety
- Adolescent Development
- Substance Use
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 12 to 14 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of North Carolina, Chapel Hill
- Last updated on ClinicalTrials.gov
- May 18, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
North Carolina · 1
- The University of North Carolina at Chapel Hill School of Medicine · Chapel Hill, NC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.